SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 408.46 |
| Enterprise Value ($M) | 222.00 |
| Book Value ($M) | 155.55 |
| Book Value / Share | 2.16 |
| Price / Book | 2.63 |
| NCAV ($M) | 137.32 |
| NCAV / Share | 1.91 |
| Price / NCAV | 2.97 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.85 |
| Return on Assets (ROA) | -0.55 |
| Return on Equity (ROE) | -0.66 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.53 |
| Current Ratio | 4.53 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 199.36 |
| Assets | 217.59 |
| Liabilities | 62.04 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Bain Capital Life Sciences Fund II, L.P. | 4.50 | 0.00 | |
| 13G | Bb Biotech Ag | 5.80 | 0.00 | |
| 13G | Avoro Capital Advisors LLC | 9.90 | ||
| 13G/A | Pfizer Inc | 0.00 | -100.00 | |
| 13G/A | Biotechnology Value Fund L P | 0.00 | -100.00 | |
| 13G | Wellington Management Group Llp | 6.79 | 381.23 | |
| 13G/A | BlackRock Inc. | 11.70 | 11.91 | |
| 13G | Sarissa Capital Management LP | 5.50 | 0.53 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| Quarterly Report – 10-Q | ||
| Annual Report – 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 90,443 | 595,042 | 15.20 | |
| 89,979 | 505,310 | 17.81 | |
(click for more detail) |
|||
(click for list of largest short owners) |
|||
| Similar Companies | |
|---|---|
| MRKR – Marker Therapeutics Inc | MRNA – Moderna Inc |
| MRNS – Marinus Pharmaceuticals Inc | MRTX – Mirati Therapeutics Inc |
| MRUS – Merus N.V. |
Financial data and stock pages provided by
Fintel.io
